Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 1
2005 2
2006 3
2007 8
2008 4
2009 1
2010 2
2011 6
2012 6
2013 5
2014 7
2015 4
2016 7
2017 6
2018 6
2019 5
2020 2
2021 2
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Paraneoplastic syndromes associated with lung cancer.
Kanaji N, Watanabe N, Kita N, Bandoh S, Tadokoro A, Ishii T, Dobashi H, Matsunaga T. Kanaji N, et al. World J Clin Oncol. 2014 Aug 10;5(3):197-223. doi: 10.5306/wjco.v5.i3.197. World J Clin Oncol. 2014. PMID: 25114839 Free PMC article. Review.
Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis.
Matsuda Y, Ye J, Yamakawa K, Mukai Y, Azuma K, Wu L, Masutomi K, Yamashita T, Daigo Y, Miyagi Y, Yokose T, Oshima T, Ito H, Morinaga S, Kishida T, Minamoto T, Kojima M, Kaneko S, Haba R, Kontani K, Kanaji N, Okano K, Muto-Ishizuka M, Yokohira M, Saoo K, Imaida K, Suizu F. Matsuda Y, et al. Among authors: kanaji n. J Natl Cancer Inst. 2023 Feb 8;115(2):208-218. doi: 10.1093/jnci/djac226. J Natl Cancer Inst. 2023. PMID: 36567450 Free PMC article.
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations.
Ninomiya T, Ishikawa N, Kozuki T, Kuyama S, Inoue K, Yokoyama T, Kanaji N, Yasugi M, Shibayama T, Aoe K, Ochi N, Fujitaka K, Kodani M, Ueda Y, Watanabe K, Bessho A, Sugimoto K, Oze I, Hotta K, Kiura K. Ninomiya T, et al. Among authors: kanaji n. Lung Cancer. 2023 Oct;184:107349. doi: 10.1016/j.lungcan.2023.107349. Epub 2023 Aug 19. Lung Cancer. 2023. PMID: 37651927 Clinical Trial.
Hairy cell leukaemia with an IGH-BRAF fusion gene.
Matsumoto K, Kakazu N, Imataki O, Kondo A, Kanaji N, Kadowaki N. Matsumoto K, et al. Among authors: kanaji n. Br J Haematol. 2023 Sep;202(6):e67-e70. doi: 10.1111/bjh.18980. Epub 2023 Jul 11. Br J Haematol. 2023. PMID: 37433466 No abstract available.
Small cell lung cancer associated with systemic sclerosis.
Kanaji N, Fujita J, Bandoh S, Fukumoto T, Ishikawa M, Haba R, Ishii T, Kubo A, Ishida T. Kanaji N, et al. Intern Med. 2005 Apr;44(4):315-8. doi: 10.2169/internalmedicine.44.315. Intern Med. 2005. PMID: 15897643 Free article. Review.
Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005).
Kanaji N, Ichihara E, Tanaka T, Ninomiya T, Kozuki T, Ishikawa N, Nishii K, Shoda H, Yamaguchi K, Kawakado K, Toyoda Y, Inoue M, Miyatake N, Watanabe N, Inoue T, Mizoguchi H, Komori Y, Kojima K, Kadowaki N. Kanaji N, et al. Lung. 2024 Feb;202(1):63-72. doi: 10.1007/s00408-023-00669-9. Epub 2024 Jan 24. Lung. 2024. PMID: 38265672 Free PMC article.
An Uncharted Constellation: TAFRO Syndrome.
Tadokoro A, Kanaji N, Hara T, Matsumoto K, Ishii T, Takagi T, Watanabe N, Kita N, Kawauchi M, Ueno M, Kadowaki N, Bandoh S. Tadokoro A, et al. Among authors: kanaji n. Am J Med. 2016 Sep;129(9):938-41. doi: 10.1016/j.amjmed.2016.05.010. Epub 2016 Jun 4. Am J Med. 2016. PMID: 27267287 No abstract available.
84 results